MicroRNA-92a-CPEB3 axis protects neurons against inflammatory neurodegeneration

Iris Winkler1, Jan Broder Engler1, Vanessa Vieira1

  • 1Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.

Science Advances
|November 24, 2023
PubMed

Insights

Researchers discovered a neuroprotective pathway involving miR-92a and CPEB3 in neuroinflammation. This miR-92a-CPEB3 axis may offer a new therapeutic target for limiting neuronal damage in diseases like multiple sclerosis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Neuroinflammation contributes to neuronal injury in neurological disorders such as multiple sclerosis (MS).
  • MicroRNAs (miRNAs) regulate neuronal stress responses, but their specific roles in neuroinflammation remain unclear.
  • Understanding miRNA-mediated mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of microRNAs in inflamed motor neurons during experimental autoimmune encephalomyelitis (EAE).
  • To identify key miRNA-mRNA interactions involved in neuronal protection or damage in neuroinflammation.
  • To explore the therapeutic potential of the identified pathway.

Main Methods:

  • Constructed a regulatory miRNA-mRNA network using cell type-specific miRNA and mRNA sequencing in EAE mice.
  • Quantified miR-92a and cytoplasmic polyadenylation element-binding protein 3 (Cpeb3) expression in inflamed neurons.
  • Utilized neuronal cultures and conditional knockout mouse models to assess the functional impact of miR-92a and Cpeb3.

Main Results:

  • Identified significant induction of miR-92a in inflamed spinal cord neurons during EAE.
  • Confirmed Cpeb3 as a direct target of miR-92a, with repressed CPEB3 levels observed in inflamed neurons (murine EAE and human MS).
  • Demonstrated that miR-92a delivery and Cpeb3 deletion conferred protection against excitotoxicity in neuronal cultures; Cpeb3 deletion reduced EAE clinical disability.

Conclusions:

  • Identified a novel neuroprotective axis: miR-92a targets Cpeb3 to mitigate inflammation-induced neuronal damage.
  • The miR-92a-Cpeb3 pathway represents a potential therapeutic target for neurological diseases characterized by neuroinflammation.
  • This study elucidates a critical molecular mechanism underlying neuronal resilience in neuroinflammatory conditions.

Related Concept Videos